2020.11_edited.jpg

PRESS

ContiVir in the media

2021

· Max Planck Institute Magdeburg
"ContiVir offers purification tool to tackle viral gene therapy manufacturing bottlenecks"
Pavel Marichal and Julian Lopez discuss SXC's advantages as a purification tool for manufacturing of adeno adeno-associated virus (AAV), widely used in human gene therapy.

2020

· BBC News
"Coronavirus: cómo son las 6 vacunas contra el virus que ya se están probando en humanos y qué países están ganando la carrera" (Spanish only)
Felipe Tapia discusses the challenges on the global manufacturing of a coronavirus vaccine.

· Investieren in Sachsen-Anhalt
"ContiVir: Zwei neue Technologien für die Herstellung und Aufreinigung von viralen Vektoren werden kombiniert" (German only) 
Dr. Pavel Marichal and Dr. Felipe Tapia are granted €1.1 Million to focus on the development of a continuous manufacturing platform for commercially relevant viral gene therapy vectors and vaccines.

· Max-Planck-Institute for Dynamics of Complex Technical Systems
"Scientists of the Bioprocess Engineering group receive a €1.1 Million Startup Grant to Advance Gene Therapy Manufacturing"
Dr. Pavel Marichal and Dr. Felipe Tapia are granted €1.1 Million to focus on the development of a continuous manufacturing platform for commercially relevant viral gene therapy vectors and vaccines.

· Nature.com
"If a coronavirus vaccine arrives, can the world make enough?"
Felipe Tapia comments on the production of a viral coronavirus vaccine.

· Cell & Gene Therapy Insights
"Suspension systems in continuous viral vector production processes"
Felipe Tapia discusses the different options for continuous culture of suspension cells for the production of virus particles.